Patient education
In-depth answers to the questions patients ask most.
"Is this FDA-approved?" "Are these donor cells?" "What's the difference between 'stem' and 'stromal'?" The most useful answers are also the ones most clinics either misuse or duck. These explainers say what we say to our patients, in the same language we use in clinical letters and research papers.
Is stem cell therapy FDA-approved?
No, with one important exception. The FDA has approved certain hematopoietic stem cell transplants for specific blood and immune disorders, but no stem cell or cellular therapy is approved for the conditions most patients are searching about.
Article 02 · Regulatory + clinicalAutologous vs. donor-derived stem cells.
Your own cells, harvested and used in the same procedure, or cells from a different person, often manufactured at scale. The FDA treats these very differently. So do we.
Article 03 · Terminology + science"Stromal" vs. "stem" cells.
A subtle word change with a real meaning. Why most peer-reviewed work now says "mesenchymal stromal cells", and why the change matters when you're evaluating a clinic.
Article 04 · Deep clinicalMesenchymal Stromal Cells, the science.
A clinician-leaning deep dive: ISCT definitions, cell-size and the first-pass effect, allogeneic immunogenicity, extracellular vesicles, senescence, and the blood–brain barrier. Heavier read than the other articles.
Article 05 · Science + methodologyClinical MSC enumeration by flow cytometry.
How we harvest bone marrow, concentrate it into BMAC, and quantify nucleated cells, viability, and MSC-enriched populations on the Sysmex XF-1600, the lab work behind the procedure, measured rather than assumed.
What is BMAC? Bone marrow aspirate concentrate, explained.
A patient-friendly walkthrough of the most common cellular-therapy procedure performed at our clinic, what BMAC is, what the harvesting and processing look like, and where the evidence is strongest.